Titan Wealth’s Eli Lilly LLY Stock Holding History

Titan Wealth’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,423	Closed	-$1.31M	–	53
2026 Q1	$1.31M	Sell	1,423 -7,143	-83%	-$7.24M	0.57%	30
2025 Q4	$9.21M	Buy	+8,566	New	+$8.19M	3.54%	11

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Titan Wealth's LLY Position: Q2 2026 in Review

Titan Wealth sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 1,423 shares — an estimated $1.31M sold.

Titan Wealth first reported a position in LLY in Q4 2025 and held it in 2 quarters. The position peaked at $9.21M in Q4 2025. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Titan Wealth reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
Titan Wealth sold 1,423 Eli Lilly shares in Q2 2026, an estimated $1.31M.
Titan Wealth first reported a position in Eli Lilly in Q4 2025 and held it in 2 quarters.
Titan Wealth's Eli Lilly position peaked at $9.21M in Q4 2025.
4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Titan Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.